Bortezomib 68001-0541-36

Package NDC

68001-0541-36

Manufacturer: Bluepoint Laboratories
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: July 31, 2022
Listing Expires: December 31, 2026
Application: ANDA209622

Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bortezomib	3.5 mg/3.5mL

Drug Class

Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]

Selected Package

68001-0541-36Selected

1 VIAL, SINGLE-USE in 1 CARTON (68001-541-36) / 3.5 mL in 1 VIAL, SINGLE-USE